Erdheim-Chester Disease: The Effect of Bisphosphonate Treatment—A Case Report


      Eyigör S, Kirazlı Y, Memis A, Başdemir G. Erdheim-Chester disease: the effect of bisphosphonate treatment—a case report.
      Erdheim-Chester disease is a distinctive pathologic and radiographic entity characterized by bilateral symmetric sclerosis of the diametaphyseal regions of long bones and infiltration of foamy lipid-laden histiocytes. It is a rare histiocytic disease of unknown etiology that is characterized pathologically by xanthogranulomatous infiltrates of multiple organs. We present a patient in her early sixties with bilateral mild knee and leg pain. The patient showed a typical bilateral symmetric medullary sclerosis at the diametaphyseal portions of long bones of the lower extremity. The diagnosis was confirmed by a bone biopsy, and bisphosphonate (alendronate, 70mg/wk) was given to the patient. After 9 months of treatment, biochemical markers of bone turnover, which were high at baseline, decreased to normal ranges. However, the radiographs showed that bone lesions had changed to lytic lesions. We propose use of bisphosphonates, such as alendronate, to decrease the biochemical markers of bone turnover. But we suggest that it is premature to conclude that bisphosphonates have any effect on lytic lesions and the progression of the disease as shown by changes in radiographs. Further studies with long-term follow-up and ultrastructural evaluation are needed.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Archives of Physical Medicine and Rehabilitation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Veyssier-Belot C.
        • Cacoub P.
        • Caparros-Lefebvre D.
        • et al.
        Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases.
        Medicine. 1996; 75 (Baltimore): 157-169
        • Pena Pardo F.J.
        • Banzo Marraco I.
        • Quirce Pisano R.
        • Hernandez Allende R.
        • Carril Carril J.M.
        [Bone scintigraphy in Erdheim-Chester disease].
        Rev Esp Med Nucl. 2003; 22 ([Spanish]): 253-256
        • Klieger M.R.
        • Schultz E.
        • Elkowitz D.E.
        • Arlen M.
        • Hajdu S.I.
        Erdheim-Chester disease.
        AJR Am J Roentgenol. 2002; 178: 429-432
        • Kenn W.
        • Eck M.
        • Allolio B.
        • et al.
        Erdheim-Chester disease: evidence for a disease entity different from Langerhans cell histiocytosis? Three cases with detailed radiological and immunohistochemical analysis.
        Hum Pathol. 2000; 31: 734-739
        • Sistermann R.
        • Katthagen B.D.
        Erdheim-Chester disease.
        Arch Orthop Trauma Surg. 2000; 120: 112-113
        • Waite R.J.
        • Doherty P.W.
        • Liepman M.
        • Woda B.
        Langerhans cell histiocytosis with the radiographic findings of Erdheim-Chester disease.
        AJR Am J Roentgenol. 1988; 150: 869-871
        • Miller R.L.
        • Sheeler L.R.
        • Bauer T.W.
        • Bukowski R.M.
        Erdheim-Chester disease.
        Am J Med. 1986; 80: 1230-1236
        • Ranty M.L.
        • Le Pessot F.
        • Billerey C.
        • Dominique S.
        • Metayer J.
        Erdheim-Chester disease. Apropos of case with autopsy findings.
        Ann Pathol. 2001; 21: 529-533
        • Wright A.R.
        • Hermann R.C.
        • Parisi J.E.
        Neurological manifestations of Erdheim-Chester disease.
        J Neurol Neurosurg Psychiatry. 1999; 66: 72-75
        • Ammann P.
        • Bosch B.
        • Buchholz S.
        • Genoni M.
        • Laube I.
        • Naegeli B.
        Cardiac tumor due to Erdheim-Chester disease.
        Am J Med. 2001; 111: 672-673
        • Kambouchner M.
        • Colby T.V.
        • Domenge C.
        • Battesti J.P.
        • Soler P.
        • Tazi A.
        Erdheim-Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone.
        Histopathology. 1997; 30: 353-358
        • Kim N.R.
        • Ko Y.H.
        • Choe Y.H.
        • Lee H.G.
        • Huh B.
        • Ahn G.H.
        Erdheim-Chester disease with extensive marrow necrosis.
        Int J Surg Pathol. 2001; 9: 73-79
        • Gotthardt M.
        • Welcke U.
        • Brandt D.
        • et al.
        The role of bone scintigraphy in patients with Erdheim-Chester disease.
        Clin Nucl Med. 2000; 25: 414-420
        • Kenn W.
        • Stabler A.
        • Zachoval R.
        • Zietz Ch
        • Raum W.
        • Wittenberg G.
        Erdheim-Chester disease.
        Eur Radiol. 1999; 9: 153-158
        • Strouse P.J.
        • Ellis B.I.
        • Shitrin L.Z.
        • Shah A.R.
        Case report 710.
        Skeletal Radiol. 1992; 21: 64-67
        • Brown R.E.
        Bisphosphonates as antialveolar macrophage therapy in pulmonary Langerhans cell histiocytosis?.
        Med Pediatr Oncol. 2001; 36: 641-643
        • Egeler R.M.
        More on pamidronate in Langerhans℉-cell histiocytosis.
        N Engl J Med. 2001; 345: 1502-1503
        • Vetter T.
        • Schneider P.
        • Kenn W.
        • Allolio B.
        High bone turnover in Erdheim-Chester disease—the effect of bisphosphonate therapy.
        Exp Clin Endocrinol Diabetes. 2002; 110 ([abstract]): 247
        • Mossetti G.
        • Rendina D.
        • Numis F.G.
        • Soma P.
        • Postiglione L.
        • Nunziata V.
        Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease.
        Clin Exp Rheumatol. 2003; 21: 232-236